Skip to main content

Massive RNAi Screens Probe for Genes Important to Cancer

Two freely available databases include data on hundreds of human cancer cell lines. 


A "hairball" of genetic interactionsNOVARTISIn what appear to be the largest RNAi screening efforts in cancer to date, two groups of scientists have tamped down the expression of thousands of genes in hundreds of human cancer cell lines. Their results, published today (July 27) in two Cell papers and made freely available to researchers, confirm the roles of the usual genetic suspects in cancer and identify new potential therapeutic targets.
The Scientist spoke with the lead author of one of the studies, Rob McDonald, a senior investigator at Novartis Institutes for BioMedical Research, about his team’s Project DRIVE endeavor. The study systematically knocked down more than 7,800 genes in nearly 400 cell lines. The other project, by researchers from the Broad Institute and Dana Farber Cancer Institute, looked for genetic dependences for cancer growth or survival among 501 cell lines.
The Scientist: What is the goal of Project DRIVE?
Rob McDonald: Very simply, it was to identify new therapeutic targets across a variety of cancer types that would hopefully impact patient care.
TS: How did you go about it?
RM: It really started with a foundational tool we have here at Novartis called the cancer cell line encyclopedia. It was developed a number of years ago in collaboration with the Broad where we collected over 1,000 different cell line models and then proceeded to characterize them for mutations and gene expression and the like.
It was our attempt to functionally annotate the cancer genome. The original phase characterized mutations and expression, but it really didn’t tell us what genes each cancer type cared about. That’s what Project DRIVE aimed to identify. So within a particular cancer type, let’s say melanoma, what genes does melanoma care about, and are they the same or different than what lung cancer cares about?
TS: How did you select the genes included in this screen?
RM: Best case scenario, we would have screened the genome, but one thing that was really important to us was to actually have that depth as far as shRNAs [short hairpin RNAs] per gene. We have 20 shRNAs per gene. That really gave us confidence in the dataset. So because we had so many reagents per gene, we did have to be a little selective about the genes we included.
We were sure to include things we know would score, [such as] oncogenes that are mutated. . . . We also looked at what genes were expressed in the cancer cell line encyclopedia.
Ultimately, we are interested in making drugs. [W]hether or not we thought the protein would be druggable was also a factor.
TS: What were some of the highlights of what you learned from this?
RM: The predictable ones are the ones where the target of the shRNA is, let’s say, mutated, like an oncogene like KRAS or BRAF. The synthetic lethal cases tend to be a more complex relationship. [In synthetic lethality, the deficiency of a set of genes causes trouble, but knocking down any one of those genes alone has no effect.] You’ll see a cancer dependence in a subset of cell lines, but the gene you’re knocking down is not directly mutated or highly expressed.
Then you need to figure out what that relationship is between the genetic dependence and the cell lines that are sensitive. That’s where the fun begins as far as I’m concerned.
TS: How can researchers access this dataset?
RM: There’s a web portal that will allow anyone to go in and look up their favorite gene and see what that phenotype is across 400 cancer cell lines. That was really important to us to further the cancer research community.
The other facet of that web-based tool is you can go in and also enter a gene of interest but then ask the question, what genes that were tested had a similar phenotype? Or, which other genes behaved similarly across the dataset? In that way you can start to understand protein complexes and protein networks.
The interview was edited for brevity.

Comments

Post a Comment

Popular posts from this blog

The Secret Science 02:The 30 Most Disturbing Human Experiments in History

Disturbing human experiments aren’t something the average person thinks too much about. Rather, the progress achieved in the last 150 years of human history is an accomplishment we’re reminded of almost daily. Achievements made in fields like biomedicine and psychology mean that we no longer need to worry about things like deadly diseases or masturbation as a form of insanity. For better or worse, we have developed more effective ways to gather information, treat skin abnormalities, and even kill each other. But what we are not constantly reminded of are the human lives that have been damaged or lost in the name of this progress. The following is a list of the 30 most disturbing human experiments in history. 30. The Tearoom Sex Study Sociologist Laud Humphreys often wondered about the men who commit impersonal sexual acts with one another in public restrooms. He wondered why “tearoom sex” — fellatio in public restrooms — led to the majority of homosexual arrests in ...
1 comment
Read more

The Strange and Stranger Case of Wyndham Lathem

A Northwestern University plague researcher has been charged with a brutal murder. Here’s what we know about him. WIKIMEDIA,  TONY WEBSTER O n July 27,  The  Chicago Tribune   reported that there was an arrest warrant issued for  Wyndham Lathem , a microbiologist at Northwestern University. The crime Lathem would later be charged with was brutal—26-year-old Trenton James Cornell-Duranleau, whose body was found in Lathem’s apartment, had been stabbed dozens of times. But Lathem was nowhere to be found. As events unfolded over the following days, it became clear he had fled from Chicago to California with a second suspect, 56-year-old Andrew Warren, a University of Oxford employee from the United Kingdom visiting the states. Along the way, the two men apparently made an anonymous $1,000 donation in Cornell-Duranleau’s name to the Lake Geneva Public Library and another donation for $5,610 to a Chicago health center. Lathem had also sent a video to fa...
Post a Comment
Read more

The 10 Biggest Research Scandals in Academic History

Despite their ostensible intelligence, academics are not at all immune to engaging in risky behaviors that erupt in spectacular displays of controversy. Even if they ultimately prove innocent or unaccountable, their situations always pose inevitable questions about the ethics and legalities behind the research and publication process. The following incidents in particular managed to spark fireworks on an epic scale, inciting a flurry of insight into what needs to be done to better prevent any potentially damaging abuses. Stephen Ambrose : This popular historian and professor enjoyed bestseller status and mainstream recognition for his inquiries into World War II, most notably  The Wild Blue , and biographies of presidents Eisenhower and Nixon. By 2002, however, it came to light that Stephen Ambrose quite shamelessly plagiarized much of his research from lesser-known contemporary Thomas Childers, the author of  Wings of Morning .  Forbes  launched a pa...
Post a Comment
Read more